Oramed Pharmaceuticals
ORMP
#9071
Rank
HK$0.95 B
Marketcap
HK$23.88
Share price
5.82%
Change (1 day)
22.39%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): -HK$31.88 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are HK$2 Million. In 2024 the company made an earning of HK$2.74 Million a decrease over its 2023 earnings that were of HK$55.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$31.88 Million-1260.26%
2024 HK$2.74 M-95.05%
2023 HK$55.44 M-119.45%
2022 -HK$0.29 Billion39.17%
2021 -HK$0.21 Billion73.93%
2020 -HK$0.12 Billion18.53%
2019 -HK$99.35 Million-16.62%
2018 -HK$0.12 Billion38.32%
2017 -HK$86.14 Million12.51%
2016 -HK$76.56 Million25.01%
2015 -HK$61.25 Million18.18%
2014 -HK$51.83 Million39.72%
2013 -HK$37.1 Million46.4%
2012 -HK$25.34 Million128.32%
2011 -HK$11.1 Million-51.47%
2010 -HK$22.87 Million35.21%
2009 -HK$16.91 Million
2007 -HK$26.59 Million607.04%
2006 -HK$3.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-HK$4.04 Billion 12,138.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$162.21 B-491,978.24%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
HK$70.81 B-214,830.06%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-HK$0.22 Billion 550.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-HK$0.54 Billion 1,518.17%๐Ÿ‡บ๐Ÿ‡ธ USA